The Impact of Medicare Part D on Hospitalization Rates

被引:57
作者
Afendulis, Christopher C. [1 ]
He, Yulei [1 ]
Zaslavsky, Alan M. [1 ]
Chernew, Michael E. [1 ]
机构
[1] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA
关键词
Medicare; prescription drugs; hospitalization; VENTRICULAR EJECTION FRACTIONS; CONGESTIVE-HEART-FAILURE; CARDIOVASCULAR EVENTS; MYOCARDIAL-INFARCTION; HEALTH-CARE; DRUG-USE; TRIAL; COST; RISK; ENALAPRIL;
D O I
10.1111/j.1475-6773.2011.01244.x
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objective. To determine whether the change in prescription drug insurance coverage associated with Medicare Part D reduced hospitalization rates for conditions sensitive to drug adherence. Data Sources/Study Setting. Hospital discharge data from 2005 to 2007 for 23 states, linked with state-level data on drug coverage. Study Design. We use a difference-in-difference-in-differences approach, comparing changes in the probability of hospitalization before and after the introduction of the Part D benefit in 2006, for individuals aged 65 and older (versus individuals aged 60-64) in states with low drug coverage in 2005 (versus those in states with high pre-Part D drug coverage). Data Collection/Extraction Methods. Hospitalization rates for selected ambulatory care sensitive conditions in 23 states were computed using data from the Census and Health Care Utilization Project. Drug coverage rates were computed using data from several sources. Principal Findings. For the conditions studied, our point estimates suggest that Part D reduced the overall rate of hospitalization by 20.5 per 10,000 (4.1 percent), representing approximately 42,000 admissions, about half of the reduction in admissions over our study period. Conclusions. The increase in drug coverage associated with Medicare Part D had positive effects on the health of elderly Americans, which reduced use of nondrug health care resources.
引用
收藏
页码:1022 / 1038
页数:17
相关论文
共 30 条
  • [1] Interaction terms in logit and probit models
    Ai, CR
    Norton, EC
    [J]. ECONOMICS LETTERS, 2003, 80 (01) : 123 - 129
  • [2] How much should we trust differences-in-differences estimates?
    Bertrand, M
    Duflo, E
    Mullainathan, S
    [J]. QUARTERLY JOURNAL OF ECONOMICS, 2004, 119 (01) : 249 - 275
  • [3] PREVENTABLE HOSPITALIZATIONS AND ACCESS TO HEALTH-CARE
    BINDMAN, AB
    GRUMBACH, K
    OSMOND, D
    KOMAROMY, M
    VRANIZAN, K
    LURIE, N
    BILLINGS, J
    STEWART, A
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (04): : 305 - 311
  • [4] β-blockers in congestive heart failure -: A Bayesian meta-analysis
    Brophy, JM
    Joseph, L
    Rouleau, JL
    [J]. ANNALS OF INTERNAL MEDICINE, 2001, 134 (07) : 550 - 560
  • [5] *CMS, 2010, CMS GUID REQ MED D
  • [6] *CMS, 2009, STAT COUNT HLTH PLAN
  • [7] Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3
  • [8] CURB JD, 1983, JAMA-J AM MED ASSOC, V250, P2814
  • [9] The implications of regional variations in medicare spending. Part 1: The content, quality, and accessibility of care
    Fisher, ES
    Wennberg, DE
    Stukel, TA
    Gottlieb, DJ
    Lucas, FL
    Pinder, EL
    [J]. ANNALS OF INTERNAL MEDICINE, 2003, 138 (04) : 273 - 287
  • [10] Fox KM, 2003, LANCET, V362, P782